Francisco Muruzabal

Dr. Francisco Muruzabal

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2001 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
GFGema Frühbeck
Gema Frühbeck
Javier Gomez-AmbrosiJavier Gomez-Ambrosi
Javier Gomez-Ambrosi
FMFrancisco Muruzabal
Francisco Muruzabal
María Ángela Burrell BustosMaría Ángela Burrell Bustos
María Ángela Burrell Bustos
The ability to ensure continous availability of energy despite highly variable supplies in the environment is a major determinant of the survival of all species. In higher organisms, including mammals, the capacity to efficiently store excess energy as triglycerides in adipocytes, from which stored energy could be rapidly released for use at other sites, was developed. To orchestrate the processes of energy storage and release, highly integrated systems operating on several physiological levels have evolved. The adipocyte is no longer considered a passive bystander, because fat cells actively secrete many members of the cytokine family, such as leptin, tumor necrosis factor-α, and interleukin-6, among other cytokine signals, which influence peripheral fuel storage, mobilization, and combustion, as well as energy homeostasis. The existence of a network of adipose tissue signaling pathways, arranged in a hierarchical fashion, constitutes a metabolic repertoire that enables the organism to adapt to a wide range of different metabolic challenges, such as starvation, stress, infection, and short periods of gross energy excess.

18 January 2010 in Arthroscopy
Verified
Journal Article
Closed access
MSMikel Sánchez
Mikel Sánchez
EAEduardo Anitua
Eduardo Anitua
JAJuan Azofra
Juan Azofra
RPRoberto Prado
Roberto Prado
FMFrancisco Muruzabal
Francisco Muruzabal
IAIsabel Andia
Isabel Andia

2 April 2015 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
EAEduardo Anitua
Eduardo Anitua
FMFrancisco Muruzabal
Francisco Muruzabal
ATAli Tayebba
Ali Tayebba
ARAna Riestra
Ana Riestra
VPVictor L. Perez
Victor L. Perez
GOGorka Orive
Gorka Orive

14 February 2012 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
EAEduardo Anitua
Eduardo Anitua
RAR. Alonso
R. Alonso
CGC. Girbau
C. Girbau
JAJ. J. Aguirre
J. J. Aguirre
FMFrancisco Muruzabal
Francisco Muruzabal
GOGorka Orive
Gorka Orive

1 August 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
EAEduardo Anitua
Eduardo Anitua
MSMikel Sanchez
Mikel Sanchez
JMJesus Merayo-Lloves
Jesus Merayo-Lloves
MFMaría de la Fuente
María de la Fuente
FMFrancisco Muruzabal
Francisco Muruzabal
GOGorka Orive
Gorka Orive
Purpose.: Plasma rich in growth factors (PRGF-Endoret) technology is an autologous platelet-enriched plasma obtained from patient's own blood, which after activation with calcium chloride allows the release of a pool of biologically active proteins that influence and promote a range of biological processes including cell recruitment, and growth and differentiation. Because ocular surface wound healing is mediated by different growth factors, we decided to explore the potential of PRGF-Endoret technology in stimulating the biological processes related with fibroblast-induced tissue repair. Furthermore, the anti-fibrotic properties of this technology were also studied. Methods.: Blood from healthy donors was collected, centrifuged and, whole plasma column (WP) and the plasma fraction with the highest platelet concentration (F3) were drawn off, avoiding the buffy coat. Primary human cells including keratocytes and conjunctival fibroblasts were used to perform the “in vitro” investigations. The potential of PRGF-Endoret in promoting wound healing was evaluated by means of a proliferation and migration assays. Fibroblast cells were induced to myofibroblast differentiation after the treatment with 2.5 ng/mL of TGF-β1. The capability of WP and F3 to prevent and inhibit TGF-β1–induced differentiation was evaluated. Results.: Results show that this autologous approach significantly enhances proliferation and migration of both keratocytes and conjunctival fibroblasts. In addition, plasma rich in growth factors prevents and inhibits TGF-β1–induced myofibroblast differentiation. No differences were found between WP and F3 plasma fractions. Conclusions.: These results suggest that PRGF-Endoret could reduce scarring while stimulating wound healing in ocular surface. F3 or whole plasma column show similar biological effects in keratocytes and conjunctival fibroblast cells.

1 June 2015 in Experimental Eye Research
Verified
Journal Article
Closed access
EAEduardo Anitua
Eduardo Anitua
MFMaría de la Fuente
María de la Fuente
FMFrancisco Muruzabal
Francisco Muruzabal
ARA. Riestra
A. Riestra
JMJ. Merayo-Lloves
J. Merayo-Lloves
GOGorka Orive
Gorka Orive